Drugs / Meningococcal C
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00314041 | Jun 1997 → Apr 1998 | meningococcal meningitis | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Meningococcal C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00314041 ↗ |
| Known as | MnCC | “Conjugate Meningococcal C (MnCC) Vaccine” NCT00314041 ↗ |
| Modality | Vaccine | “group C meningococcal conjugate vaccine (MnCC)” NCT00314041 ↗ |